Precigen
PGENPrecigen, Inc (formerly Intrexon Corporation, NASDAQ: PGEN) is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies enginee …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Precigen
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 9/30/2025 | Sell | Kindler, Jeffrey B. | Director | $3.4 | $361,109 |
| 9/30/2025 | Sell | Kirk, Randal J. | Director | $3.4 | $6,170,964 |
| 9/29/2025 | Sell | Kindler, Jeffrey B. | Director | $3.6 | $243,083 |
| 9/29/2025 | Buy | Tennant, Phil | Chief Commercial Officer | $3.6 | $21,480 |
| 9/26/2025 | Buy | Thomasian, Harry Jr. | Chief Financial Officer | $3.4 | $10,027 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)